This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Public vs. Private Oversight of Mobile Health. mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. The post Who will regulate mHealth? Below are abstracts from this month’s update. John Moore III.
Published by HIMSS Media, this is a reliable, daily updated source for all your healthcare IT news, whether you're looking for the most recent updates on meaningfuluse rules, tips for implementing your EMR successfully, or are wondering how to leverage patient data to provide better care. Healthcare IT News. The cHealth Blog.
For many, the delay of Stage 3 of the MeaningfulUse program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. How Will the Market Respond?
While payers evangelize the idea of understanding all the other parts of our lives, they shouldn’t forget our tendencies as patients – how we perceive and realistically interact with our health insurer versus our doctors, nurses, hospitals, pharmacies, and so on. EHR Vendors: Mixed Reviews.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content